The science of
metabolic health.
Evidence-based articles on GLP-1 therapy, obesity biology, and metabolic health — written for Indian patients, reviewed by doctors.
Why You're Not Losing Weight in a Calorie Deficit (The Insulin Resistance Trap)
You're eating 1,500 calories and walking daily, and the scale won't move. It's probably not your willpower — it's insulin.
Read article →
Why You're Not Losing Weight in a Calorie Deficit (The Insulin Resistance Trap)
You're eating 1,500 calories and walking daily, and the scale won't move. It's probably not your willpower — it's insulin.
The Asian Indian Phenotype: Why Your BMI Is Normal but Your Belly Fat Is Dangerous
Your BMI says normal, but your report flags pre-diabetes or a fatty liver. For Indians, that contradiction is biology, not bad luck.
Why a Branded Weight-Loss Pen Costs ₹16,000 in India When the Molecule Costs ₹1,500
Branded pens cost ₹11,000–₹26,000 a month; generic semaglutide now starts near ₹1,500. The gap isn't the medicine.
Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You? (2026 India Guide)
Tirzepatide averages 20–22% weight loss vs ~15% for semaglutide — and costs several times more in India. After the 2026 patent expiry, here's how doctors actually choose.
PCOS and Weight Loss: How GLP-1 Breaks the Hormonal Cycle
Insulin resistance drives PCOS weight gain — and GLP-1 medications target insulin signalling directly. Here's the evidence and what to expect.
Pre-Diabetes in India: How GLP-1 Can Reverse It Before It's Too Late
Tens of millions of Indians have pre-diabetes and most don't know it. GLP-1 therapy with lifestyle change has been shown to reverse it in a large share of patients.
Ozempic Price in India 2026 — and the ₹5,999 Alternative Your Doctor Can Prescribe Today
Ozempic's price collapsed in 2026 after the semaglutide patent expired. Here's the real monthly cost, why it kept going out of stock, and the same-molecule alternative from ₹5,999.
GLP-1 Medications in India: A Complete 2026 Guide
Ozempic, Wegovy, Mounjaro, and generics — what's available in India, what's DCGI-approved, what each costs in 2026, and how to get a legitimate prescription.
Why Waist Size Predicts Metabolic Risk Better Than BMI for Indians
Indian bodies store more visceral fat at lower BMIs. A waist above 90 cm (men) or 80 cm (women) is a stronger trigger for GLP-1 treatment than BMI alone.
Weight Loss Injections in India: 9 Myths, Answered Plainly
Are they steroids? Do you regain the weight? Are they safe? India's most common questions about GLP-1 injections, answered plainly by our medical team.
Generic Semaglutide in India 2026: Brands, Prices, and How to Choose Safely
Over 40 generic semaglutide brands launched in India after the March 2026 patent expiry, from ₹1,290/month. What they cost, how they differ, and how to choose without putting your health at risk.
Rybelsus Price in India 2026 — and Why the Daily Pill May Be the Slow Road
Rybelsus is oral semaglutide — the same molecule as Ozempic in a daily pill. What it costs in India in 2026, how its results compare to the injection, and which one actually suits you.
Ozempic or Wegovy Out of Stock in India? Here Are Your Options
Pharmacy out of Ozempic or Wegovy? A missed dose stalls progress. Here are the same-molecule, in-stock alternatives and how to avoid supply gaps in 2026.
Buying Semaglutide Online in India: What's Legal, What's a Scam, and How to Do It Safely
Semaglutide is cheap and everywhere online now — and so are the scams and counterfeits. How to buy it legally and safely in India, and the red flags to avoid.
The Peptide Wellness Trend, Decoded: What's Evidence-Based, What's Hype, What's Just Unregulated
Peptides are everywhere in wellness content — fat loss, recovery, anti-ageing. Some are real medicine; most sold online are unapproved. A doctor-led look at what's evidence-based and what's risky.
Retatrutide in India: The 28% Weight-Loss Drug Everyone's Talking About — and Why You Can't Get It Yet
Retatrutide produced up to 28% weight loss in Phase 3 trials — the strongest ever recorded. But it's not approved anywhere, and online 'research peptide' versions are dangerous. Here's the honest picture.
GLP-1 Drugs Out-Earned the AI Labs in 2025. Here's What That Tells Us.
In 2025 the bigger money story wasn't chatbots — it was metabolic. Two drugmakers out-earned the marquee AI labs.
"Ozempic Babies": Why Some Women Get Pregnant on Semaglutide
Women told they likely couldn't conceive are getting pregnant on semaglutide. Here's why — and the critical safety caveat.
Why People on Semaglutide Suddenly Stop Wanting to Drink
People who weren't trying to quit drinking find the urge has switched off on semaglutide. It's a clue about how the drug works.